NCT05574673View on ClinicalTrials.gov

Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype

RecruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

December 1, 2028

Study Completion Date

December 1, 2028

Conditions
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Interventions
OTHER

Standard of care

Patients receive standard of care treatment according to local and national guidelines

Trial Locations (1)

2100

RECRUITING

Rigshospitalet, København Ø

All Listed Sponsors
lead

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

OTHER